Molecular Therapy

Molecular Therapy, published by the American Society of Gene and Cell Therapy (ASGCT), is a premier peer-reviewed journal in the field of biomedical research, with a specific focus on the development and clinical translation of genetic, cellular, and molecular therapies. Since its inception in 2000, the journal has established itself as a leading voice in the discipline, consistently maintaining a JCR Quartile ranking of Q1 and an Impact Factor of 11.400 as of 2026, placing it among the top-tier publications in biotechnology and applied microbiology. The scope of Molecular Therapy encompasses a broad range of topics, including gene editing, vector development, viral and non-viral gene delivery, stem cell engineering, immunotherapy, oligonucleotide therapeutics, and the molecular mechanisms underlying disease pathogenesis and treatment. The journal publishes original research articles, comprehensive reviews, brief reports, and commentaries, all of which undergo rigorous peer review to ensure scientific integrity and high impact. Its target audience includes academic researchers, clinical investigators, biotechnologists, and medical professionals engaged in translating basic discoveries into viable therapeutic strategies. A notable feature of Molecular Therapy is its fully open access model, which ensures that all published content is freely and permanently available online, thereby maximizing the dissemination and accessibility of cutting-edge research. With its strong editorial leadership, high citation metrics, and dedicated focus on translational science, Molecular Therapy remains an essential resource for advancing the field of molecular medicine.